Court Rules In Pfizer's Favor In Norvasc Patent Case
In yet another setback for Dutch drug maker Synthon Pharmaceuticals Inc., a U.S. judge has agreed with defendant Pfizer Inc. that Synthon's patent for generic Norvasc was gleaned through inequitable conduct....To view the full article, register now.
Already a subscriber? Click here to view full article